๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD ยท Real-Time Price ยท USD
1.710
-0.100 (-5.52%)
At close: Nov 20, 2026, 4:00 PM EST
1.709
-0.001 (-0.06%)
After-hours: Nov 20, 2026, 7:50 PM EST

TherapeuticsMD Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.753.021.761.369.962.57
Revenue Growth
33.94%71.61%35.25%-98.14%2619.12%-96.03%
Gross Profit
3.753.021.761.368.571.17
Operating Income
-1.41-2.37-3.49-8.5210.66-71.58
Net Income
0.12-0.57-2.18-10.28112-172.42
Earnings Per Share
0.01-0.05-0.19-0.9911.95-21.66
EPS Growth
-59.66%-----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
10.457.485.064.3338.0764.91
Total Debt
4.216.17.188.018.76197.69
Net Cash (Debt)
6.241.39-2.12-3.6829.31-132.79
Net Cash Growth
886.87%-----
Net Cash Per Share
0.540.12-0.18-0.353.13-16.68

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
3.332.420.73-48.14-4.08-142.69
Capital Expenditures
------0.03
Free Cash Flow
3.332.420.73-48.14-4.08-142.73
Free Cash Flow Growth
61.12%231.15%----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%98.00%45.51%
Operating Margin
-37.73%-78.33%-198.30%-654.61%15.24%-2781.85%
Pretax Margin
5.02%-21.61%-133.05%-594.62%1.54%-3082.20%
Profit Margin
3.26%-18.83%-123.85%-789.40%160.08%-6700.93%
FCF Margin
88.97%80.21%41.57%-3697.46%-5.83%-5547.10%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
162.24---0.47-
Forward PE
-25.0925.0925.09--
P/FCF Ratio
5.947.7813.55---
PS Ratio
5.286.245.6319.790.7658.71